These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30480810)

  • 21. Multi-Omics Analyses Show Disease, Diet, and Transcriptome Interactions With the Virome.
    Mihindukulasuriya KA; Mars RAT; Johnson AJ; Ward T; Priya S; Lekatz HR; Kalari KR; Droit L; Zheng T; Blekhman R; D'Amato M; Farrugia G; Knights D; Handley SA; Kashyap PC
    Gastroenterology; 2021 Oct; 161(4):1194-1207.e8. PubMed ID: 34245762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of Blastocystis sp. and Dientamoeba fragilis in irritable bowel syndrome: a systematic review and meta-analysis.
    Rostami A; Riahi SM; Haghighi A; Saber V; Armon B; Seyyedtabaei SJ
    Parasitol Res; 2017 Sep; 116(9):2361-2371. PubMed ID: 28668983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blastocystis is associated with decrease of fecal microbiota protective bacteria: comparative analysis between patients with irritable bowel syndrome and control subjects.
    Nourrisson C; Scanzi J; Pereira B; NkoudMongo C; Wawrzyniak I; Cian A; Viscogliosi E; Livrelli V; Delbac F; Dapoigny M; Poirier P
    PLoS One; 2014; 9(11):e111868. PubMed ID: 25365580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Irritable Bowel Syndrome, Emotion Regulation, and Gut Microbiota].
    Fukudo S
    Brain Nerve; 2016 Jun; 68(6):607-15. PubMed ID: 27279158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.
    Distrutti E; Monaldi L; Ricci P; Fiorucci S
    World J Gastroenterol; 2016 Feb; 22(7):2219-41. PubMed ID: 26900286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Irritable bowel syndrome following Clostridium difficile infection.
    Dayananda P; Wilcox MH
    Curr Opin Gastroenterol; 2019 Jan; 35(1):1-5. PubMed ID: 30335629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blastocystis subtypes isolated from irritable bowel syndrome patients and co-infection with Helicobacter pylori.
    El-Badry AA; Abd El Wahab WM; Hamdy DA; Aboud A
    Parasitol Res; 2018 Jan; 117(1):127-137. PubMed ID: 29138961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of Dientamoeba fragilis and Blastocystis spp. in Irritable Bowel Syndrome].
    Mumcuoğlu I; Coşkun FA; Aksu N; Pürnak T; Güngör C
    Turkiye Parazitol Derg; 2013; 37(2):73-7. PubMed ID: 23955902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunomodulation of enteric neural function in irritable bowel syndrome.
    O'Malley D
    World J Gastroenterol; 2015 Jun; 21(24):7362-6. PubMed ID: 26139983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fecal microbiota transplantation for managing irritable bowel syndrome.
    El-Salhy M; Mazzawi T
    Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):439-445. PubMed ID: 29493330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The gut microbiome and irritable bowel syndrome: State of art review.
    Salem AE; Singh R; Ayoub YK; Khairy AM; Mullin GE
    Arab J Gastroenterol; 2018 Sep; 19(3):136-141. PubMed ID: 29935865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of Dientamoeba fragilis and Blastocystis in patients from Turkey with ulcerative colitis and irritable bowel syndrome: Any relation with genotypes?
    Unalan-Altintop T; Vahabov C; Ergunay K; Kurt O; Kav T; Akyon Y; Erguven S
    Acta Trop; 2022 Jul; 231():106451. PubMed ID: 35390312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomarkers as a diagnostic tool for irritable bowel syndrome: where are we?
    Camilleri M; Halawi H; Oduyebo I
    Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):303-316. PubMed ID: 28128666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets.
    Dupont HL
    Aliment Pharmacol Ther; 2014 May; 39(10):1033-42. PubMed ID: 24665829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenic factors involved in the development of irritable bowel syndrome: focus on a microbial role.
    Bolino CM; Bercik P
    Infect Dis Clin North Am; 2010 Dec; 24(4):961-75, ix. PubMed ID: 20937460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parasitic infections in irritable bowel syndrome patients: evidence to propose a possible link, based on a case-control study in the south of Iran.
    Shafiei Z; Esfandiari F; Sarkari B; Rezaei Z; Fatahi MR; Hosseini Asl SMK
    BMC Res Notes; 2020 Jun; 13(1):264. PubMed ID: 32487206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Irritable bowel syndrome: a review of the general aspects and the potential role of vitamin D.
    Barbalho SM; Goulart RA; Araújo AC; Guiguer ÉL; Bechara MD
    Expert Rev Gastroenterol Hepatol; 2019 Apr; 13(4):345-359. PubMed ID: 30791775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Irritable bowel syndrome: a microbiome-gut-brain axis disorder?
    Kennedy PJ; Cryan JF; Dinan TG; Clarke G
    World J Gastroenterol; 2014 Oct; 20(39):14105-25. PubMed ID: 25339800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last?
    Bixquert Jiménez M
    Rev Esp Enferm Dig; 2009 Aug; 101(8):553-64. PubMed ID: 19785495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Irritable bowel syndrome in Egyptian patients: plausible risk factors and association with intestinal protozoa.
    Salem AI; El-Taweel HA; Madkour MA; Abd El-Latif NF; Abd-Elrazeq ES
    Trop Doct; 2019 Jul; 49(3):184-188. PubMed ID: 30885054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.